Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine
Date
2019
Type:
Preprint
item.page.extent
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Ltd.
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
mechanistic understanding of the diverse clinical manifestations of Parkinson's disease (PD) and variable patient response to treatments is lacking. Genetically diverse PD model organisms can be used to map modifier genes and understand clinically relevant phenotypes of varying severity. This strategy can accelerate the pace of discoveries for precision medicine purposes.
Description
Centro de Genética y Genómica (ICIM)
item.page.coverage.spatial
item.page.sponsorship
Citation
Trends Mol Med. 2019 Dec;25(12):1052-1055. doi: 10.1016/j.molmed.2019.09.004.
Keywords
Parkinson’s disease, Customized therapies, Genome-wide association studies, Inbred animal organisms, Modifier genes, Precision medicine